Conquering Diseases

Study To Evaluate The Efficacy And Safety Of An Investigational Drug For Mild To Moderate Covid-19 Illness


Seeking men and women who are suffering COVID-19, but have not yet been hospitalized for a study of an investigational drug for mild to moderate COVID-19.


We are studying an investigational drug to reduce COVID-19 virus in people with mild to moderate COVID-19. Participants in this trial will receive either a placebo (looks like the drug, but doesn't contain active medicine) or one of up to four different strengths of the investigational drug.

What we're hoping for

Evaluate how safe an investigational drug is and how well it will work to help people with mild to moderate COVID-19.

Additional Information Identifier: NCT04427501

 Principal Investigator

Robert  Finberg, MD

University of Massachusetts Medical School

 Study Contact

The Office  of Clinical Research



UMMS University Campus

55 Lake Ave North 

Worcester,MA 01655